BioSpace News Archive

As part of the Trump Administration’s all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments.

Personalis, Inc. announced that company management will participate in the 1-on-1 meetings at the upcoming 19th Annual Needham Virtual Healthcare Conference from Tuesday, April 14, 2020 through Wednesday, April 15, 2020.

To support rapid response efforts to the COVID-19 pandemic, the American National Standards Institute is providing access to key international standards supporting biological evaluation of medical devices; protective clothing used in health care settings; and business continuity management, security, and resilience.

Select Medical Holdings Corporation, announced a change in the location of the Company’s 2020 Annual Meeting of Stockholders.

Daiichi Sankyo granted non-exclusive license to Ultragenyx HeLa manufacturing platform

Amgen K.K. Will Focus on Bringing Amgen’s Full Global Pipeline to Japanese Patients.

Shortages are most common in the hospital setting and are most acute in New York, where the majority of COVID-19 patients are receiving care.

Ascletis Pharma Inc. announces that its partner Sagimet Biosciences, will present clinical and preclinical data on non-alcoholic steatohepatitis drug candidate TVB-2640 at the upcoming European Association for the Study of the Liver International Liver Congress™ 2020 in London, which has been postponed to 25-28 August..

Company highlights significant R&D investments, progress in cell therapy, especially in CAR-T Trials Targeting Gastric Cancer and Other Pipelines

The novel single-use micro-endoscope with multiple working channels, eliminates the risk of transmitting infections between patients.